Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1996-10-28
1998-02-17
Schofer, Joseph L.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
514318, 514323, 540519, 546199, 546194, 546193, 544333, A61F 200, A01N 4340, A61K 31445
Patent
active
057189129
ABSTRACT:
benzimidazolones, their compositions and method of use. The novel compounds are selective muscarinic agonists of the m2 subtype with low activity at the m3 subtype. The compounds are effective for the treatment of glaucoma with fewer side effects than the pilocarpine therapy.
REFERENCES:
patent: 5574044 (1996-11-01), Thompson
patent: 5591708 (1997-01-01), Richter
patent: 5591890 (1997-01-01), Jacobson
R. Feifel, et al., Br. J. Pharmacol, 99, pp. 455-460 (1990).
F. Dorje, et al., J. Pharmacol. and Exp. Thera., 256(2), pp. 727-733 (1991) .
Bell Ian M.
Mallorga Pierre
Munson Peter M.
Ransom Richard W.
Sugrue Michael F.
Ayler Sylvia A.
Daniel Mark R.
Faulkner D.
Merck & Co. , Inc.
Schofer Joseph L.
LandOfFree
Muscarine agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Muscarine agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Muscarine agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1782440